Notably, the sgCas9‐AdV/Gel substantially inhibited tumor progression and prolonged survival time, with six out of eight mice maintained alive during the whole observation period up to 40 days, whereas anti‐PD‐L1 exhibited much less ability to suppress tumor growth or extent overall survival of mice (Figure 5A–E). Here, CD274 is linked to neoplasm.